Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion type Assertion NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_head.
- NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion description "[Sorafenib (SOR), a vascular endothelial growth factor receptor (VEGFR) inhibitor, is in wide clinical use for the treatment and prevention of liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_provenance.
- NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion evidence source_evidence_literature NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_provenance.
- NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion SIO_000772 25176394 NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_provenance.
- NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion wasDerivedFrom befree-2016 NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_provenance.
- NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_assertion wasGeneratedBy ECO_0000203 NP1215798.RAvrU7j9QZJSvQFGkMrC6Pr3lMjjWU0RFiZWsJiyVjLrM130_provenance.